We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say.
We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say.